These opportunities are not managed nor endorsed by RCPCH. Though we do our best to ensure they are relevant and high quality, we cannot take any responsibility for their content or accuracy. If you have questions or would like to submit a joint funding application with the College, contact us on email@example.com.
Inviting applications for medical research that has the potential to benefit children and adults with Ataxia Telangiectasia (A-T).
This is a new research grant by ESPID and INOPSU to support infection surveillance across two or more European countries and aims to facilitate infection surveillance research in Europe by ESPID researchers.
GOSH Charity and LifeArc are inviting translational, milestone-driven applications which aim to improve the prevention, diagnosis, prognosis, or treatment of rare disease or that focus on developing research tools that increase the efficiency of developing interventions in rare disease. The scheme is designed to support applications on the translational pathway with the expectation that researchers will continue to develop their therapy/ diagnostic after GOSH charity/LifeArc funding, either by s...
Applications are invited for studies into the histiocytic disorder Paediatric Langerhans Cell Histiocytosis. Histio UK will consider scientific and clinical research on the epidemiology, pathogenesis, diagnosis, treatment and clinical care of patients with Paediatric Langerhans Cell Histiocytosis.
Supports translational rare disease research projects. Focus will be on developing an intervention (therapeutic, device or diagnostic) that will address a significant, unaddressed need for rare disease patients and on research which has a credible translational and development path to reaching patients.
Through strategic grant funding, the MRC supports a number of ongoing research initiatives.
Funding projects that will help find a cure and / or a treatment for any form of centronuclear and myotubular myopathy (congenital X-linked recessive; congenital autosomal recessive; autosomal dominant), focusing on research that would not generally be funded by public or industrial funding sources.
Awarded to outstanding scientists who are in the early stages of their career (no more than eight years of post-doc experience) and have the potential to become leaders in the field of tuberous sclerosis research.
Intended for postgraduates of high academic calibre working alongside academics with a track record in research within the field of tuberous sclerosis.